Clinical Trials Search

Titlesort ascending Intervention NCT ID Sponsor Status
Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment Quality-of-Life Assessment, Questionnaire Administration NCT03516942 ECOG-ACRIN Cancer Research Group Active, not recruiting
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial... Exemestane, Laboratory Biomarker Analysis, Questionnaire Administration, Pharmacokinetic Study NCT03300557 National Cancer Institute (NCI) Recruiting
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast... Screening Mammography, Biospecimen Collection NCT03609021 Alliance for Clinical Trials in Oncology Recruiting
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous... Erlotinib Hydrochloride, Erlotinib NCT02961374 National Cancer Institute (NCI) Active, not recruiting
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Erlotinib NCT02273362 National Cancer Institute (NCI) Active, not recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure... Assessment of Therapy Complications, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration NCT01790152 Children's Oncology Group Recruiting
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer Interview, Questionnaire Administration NCT03963739 Wake Forest University Health Sciences Recruiting
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III... Oxaliplatin, Duloxetine Hydrochloride, Duloxetine, Quality-of-Life Assessment, Questionnaire Administration, Placebo NCT04137107 Alliance for Clinical Trials in Oncology Recruiting
Dolcanatide in Preventing Colorectal Cancer in Healthy Volunteers Laboratory Biomarker Analysis, Questionnaire Administration, Dolcanatide, Placebo Administration NCT03300570 National Cancer Institute (NCI) Active, not recruiting
Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American... Docetaxel, Paclitaxel, Quality-of-Life Assessment, Questionnaire Administration NCT04001829 ECOG-ACRIN Cancer Research Group Recruiting

Pages